Compliance Rate
Compliance Rate
50.0%
Compliant submissions
1
Incompliant submissions
1
Total trials
2
My Organizations' Clinical Trials
Showing 775 of 3499 entries
View as:
Phase: N/A
Priority: Normal
Start: 01/31/09
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 05/08/17
End: 10/03/25
Due: 10/03/26
Phase: N/A
Priority: Normal
Start: 10/31/08
End: 10/31/14
Due: 10/31/15
Phase: N/A
Priority: Normal
Start: 10/31/01
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 06/30/07
End: 07/31/12
Due: 07/31/13
Phase: N/A
Priority: Normal
Start: 04/30/04
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 01/04/24
End: 10/23/26
Due: 10/23/27
Phase: N/A
Priority: Normal
Start: 05/13/03
End: 10/01/12
Due: 10/01/13
Phase: N/A
Priority: Normal
Start: 10/11/10
End: 12/20/10
Due: 12/20/11
Phase: N/A
Priority: Normal
Start: 10/24/22
End: 12/31/28
Due: 12/31/29
Phase: N/A
Priority: Normal
Start: 03/12/98
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 09/30/10
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 07/05/12
End: 12/31/23
Due: 12/31/24
Phase: N/A
Priority: Normal
Start: 03/31/95
End: 11/30/03
Due: 11/30/04
Phase: N/A
Priority: Normal
Start: 09/08/15
End: 12/31/25
Due: 12/31/26
Phase: N/A
Priority: Normal
Start: 08/31/05
End: 09/30/09
Due: 09/30/10
Phase: N/A
Priority: Normal
Start: 08/05/19
End: 03/31/30
Due: 03/31/31
Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer
Phase: N/A
Priority: Normal
Start: 02/08/11
End: 06/02/25
Due: 06/02/26
Phase: N/A
Priority: Normal
Start: 12/27/23
End: 11/01/25
Due: 11/01/26
Phase: N/A
Priority: Normal
Start: 06/30/99
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 04/13/17
End: 02/18/20
Due: 02/18/21
Phase: N/A
Priority: Normal
Start: 05/31/98
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 11/10/15
End: 01/23/26
Due: 01/23/27
Phase: N/A
Priority: Normal
Start: 05/15/09
End: 02/22/26
Due: 02/22/27
Phase: N/A
Priority: Normal
Start: 12/23/10
End: 03/18/26
Due: 03/18/27